Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State

Melissa P. Wasserstein, Mary Andriola, Georgianne Arnold, Alan Aron, Patricia Duffner, Richard W. Erbe, Maria L. Escolar, Lissette Estrella, Patricia Galvin-Parton, Alejandro Iglesias, Denise M. Kay, David F. Kronn, Joanne Kurtzberg, Jennifer M. Kwon, Thomas J. Langan, Paul A. Levy, Thomas P. Naidich, Joseph J. Orsini, Joan E. Pellegrino, James M. ProvenzaleDavid A. Wenger, Michele Caggana

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background:Early infantile Krabbe disease is rapidly fatal, but hematopoietic stem cell transplantation (HSCT) may improve outcomes if performed soon after birth. New York State began screening all newborns for Krabbe disease in 2006.Methods:Infants with abnormal newborn screen results for Krabbe disease were referred to specialty-care centers. Newborns found to be at high risk for Krabbe disease underwent a neurodiagnostic battery to determine the need for emergent HSCT.Results:Almost 2 million infants were screened. Five infants were diagnosed with early infantile Krabbe disease. Three died, two from HSCT-related complications and one from untreated disease. Two children who received HSCT have moderate to severe developmental delays. Forty-six currently asymptomatic children are considered to be at moderate or high risk for development of later-onset Krabbe disease.Conclusions:These results show significant HSCT-associated morbidity and mortality in early infantile Krabbe disease and raise questions about its efficacy when performed in newborns diagnosed through newborn screening. The unanticipated identification of "at risk" children introduces unique ethical and medicolegal issues. New York's experience raises questions about the risks, benefits, and practicality of screening newborns for Krabbe disease. It is imperative that objective assessments be made on an ongoing basis as additional states begin screening for this disorder.

Original languageEnglish (US)
Pages (from-to)1235-1243
Number of pages9
JournalGenetics in Medicine
Volume18
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Globoid Cell Leukodystrophy
Newborn Infant
Hematopoietic Stem Cell Transplantation
Ethics
Parturition
Morbidity

Keywords

  • Globoid cell leukodystrophy
  • Krabbe disease
  • newborn screening

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State. / Wasserstein, Melissa P.; Andriola, Mary; Arnold, Georgianne; Aron, Alan; Duffner, Patricia; Erbe, Richard W.; Escolar, Maria L.; Estrella, Lissette; Galvin-Parton, Patricia; Iglesias, Alejandro; Kay, Denise M.; Kronn, David F.; Kurtzberg, Joanne; Kwon, Jennifer M.; Langan, Thomas J.; Levy, Paul A.; Naidich, Thomas P.; Orsini, Joseph J.; Pellegrino, Joan E.; Provenzale, James M.; Wenger, David A.; Caggana, Michele.

In: Genetics in Medicine, Vol. 18, No. 12, 01.12.2016, p. 1235-1243.

Research output: Contribution to journalArticle

Wasserstein, MP, Andriola, M, Arnold, G, Aron, A, Duffner, P, Erbe, RW, Escolar, ML, Estrella, L, Galvin-Parton, P, Iglesias, A, Kay, DM, Kronn, DF, Kurtzberg, J, Kwon, JM, Langan, TJ, Levy, PA, Naidich, TP, Orsini, JJ, Pellegrino, JE, Provenzale, JM, Wenger, DA & Caggana, M 2016, 'Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State', Genetics in Medicine, vol. 18, no. 12, pp. 1235-1243. https://doi.org/10.1038/gim.2016.35
Wasserstein, Melissa P. ; Andriola, Mary ; Arnold, Georgianne ; Aron, Alan ; Duffner, Patricia ; Erbe, Richard W. ; Escolar, Maria L. ; Estrella, Lissette ; Galvin-Parton, Patricia ; Iglesias, Alejandro ; Kay, Denise M. ; Kronn, David F. ; Kurtzberg, Joanne ; Kwon, Jennifer M. ; Langan, Thomas J. ; Levy, Paul A. ; Naidich, Thomas P. ; Orsini, Joseph J. ; Pellegrino, Joan E. ; Provenzale, James M. ; Wenger, David A. ; Caggana, Michele. / Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State. In: Genetics in Medicine. 2016 ; Vol. 18, No. 12. pp. 1235-1243.
@article{fd2a421654ef468787dd1f5e32107093,
title = "Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State",
abstract = "Background:Early infantile Krabbe disease is rapidly fatal, but hematopoietic stem cell transplantation (HSCT) may improve outcomes if performed soon after birth. New York State began screening all newborns for Krabbe disease in 2006.Methods:Infants with abnormal newborn screen results for Krabbe disease were referred to specialty-care centers. Newborns found to be at high risk for Krabbe disease underwent a neurodiagnostic battery to determine the need for emergent HSCT.Results:Almost 2 million infants were screened. Five infants were diagnosed with early infantile Krabbe disease. Three died, two from HSCT-related complications and one from untreated disease. Two children who received HSCT have moderate to severe developmental delays. Forty-six currently asymptomatic children are considered to be at moderate or high risk for development of later-onset Krabbe disease.Conclusions:These results show significant HSCT-associated morbidity and mortality in early infantile Krabbe disease and raise questions about its efficacy when performed in newborns diagnosed through newborn screening. The unanticipated identification of {"}at risk{"} children introduces unique ethical and medicolegal issues. New York's experience raises questions about the risks, benefits, and practicality of screening newborns for Krabbe disease. It is imperative that objective assessments be made on an ongoing basis as additional states begin screening for this disorder.",
keywords = "Globoid cell leukodystrophy, Krabbe disease, newborn screening",
author = "Wasserstein, {Melissa P.} and Mary Andriola and Georgianne Arnold and Alan Aron and Patricia Duffner and Erbe, {Richard W.} and Escolar, {Maria L.} and Lissette Estrella and Patricia Galvin-Parton and Alejandro Iglesias and Kay, {Denise M.} and Kronn, {David F.} and Joanne Kurtzberg and Kwon, {Jennifer M.} and Langan, {Thomas J.} and Levy, {Paul A.} and Naidich, {Thomas P.} and Orsini, {Joseph J.} and Pellegrino, {Joan E.} and Provenzale, {James M.} and Wenger, {David A.} and Michele Caggana",
year = "2016",
month = "12",
day = "1",
doi = "10.1038/gim.2016.35",
language = "English (US)",
volume = "18",
pages = "1235--1243",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State

AU - Wasserstein, Melissa P.

AU - Andriola, Mary

AU - Arnold, Georgianne

AU - Aron, Alan

AU - Duffner, Patricia

AU - Erbe, Richard W.

AU - Escolar, Maria L.

AU - Estrella, Lissette

AU - Galvin-Parton, Patricia

AU - Iglesias, Alejandro

AU - Kay, Denise M.

AU - Kronn, David F.

AU - Kurtzberg, Joanne

AU - Kwon, Jennifer M.

AU - Langan, Thomas J.

AU - Levy, Paul A.

AU - Naidich, Thomas P.

AU - Orsini, Joseph J.

AU - Pellegrino, Joan E.

AU - Provenzale, James M.

AU - Wenger, David A.

AU - Caggana, Michele

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Background:Early infantile Krabbe disease is rapidly fatal, but hematopoietic stem cell transplantation (HSCT) may improve outcomes if performed soon after birth. New York State began screening all newborns for Krabbe disease in 2006.Methods:Infants with abnormal newborn screen results for Krabbe disease were referred to specialty-care centers. Newborns found to be at high risk for Krabbe disease underwent a neurodiagnostic battery to determine the need for emergent HSCT.Results:Almost 2 million infants were screened. Five infants were diagnosed with early infantile Krabbe disease. Three died, two from HSCT-related complications and one from untreated disease. Two children who received HSCT have moderate to severe developmental delays. Forty-six currently asymptomatic children are considered to be at moderate or high risk for development of later-onset Krabbe disease.Conclusions:These results show significant HSCT-associated morbidity and mortality in early infantile Krabbe disease and raise questions about its efficacy when performed in newborns diagnosed through newborn screening. The unanticipated identification of "at risk" children introduces unique ethical and medicolegal issues. New York's experience raises questions about the risks, benefits, and practicality of screening newborns for Krabbe disease. It is imperative that objective assessments be made on an ongoing basis as additional states begin screening for this disorder.

AB - Background:Early infantile Krabbe disease is rapidly fatal, but hematopoietic stem cell transplantation (HSCT) may improve outcomes if performed soon after birth. New York State began screening all newborns for Krabbe disease in 2006.Methods:Infants with abnormal newborn screen results for Krabbe disease were referred to specialty-care centers. Newborns found to be at high risk for Krabbe disease underwent a neurodiagnostic battery to determine the need for emergent HSCT.Results:Almost 2 million infants were screened. Five infants were diagnosed with early infantile Krabbe disease. Three died, two from HSCT-related complications and one from untreated disease. Two children who received HSCT have moderate to severe developmental delays. Forty-six currently asymptomatic children are considered to be at moderate or high risk for development of later-onset Krabbe disease.Conclusions:These results show significant HSCT-associated morbidity and mortality in early infantile Krabbe disease and raise questions about its efficacy when performed in newborns diagnosed through newborn screening. The unanticipated identification of "at risk" children introduces unique ethical and medicolegal issues. New York's experience raises questions about the risks, benefits, and practicality of screening newborns for Krabbe disease. It is imperative that objective assessments be made on an ongoing basis as additional states begin screening for this disorder.

KW - Globoid cell leukodystrophy

KW - Krabbe disease

KW - newborn screening

UR - http://www.scopus.com/inward/record.url?scp=85000868706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000868706&partnerID=8YFLogxK

U2 - 10.1038/gim.2016.35

DO - 10.1038/gim.2016.35

M3 - Article

C2 - 27171547

AN - SCOPUS:85000868706

VL - 18

SP - 1235

EP - 1243

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 12

ER -